Healthcare Industry Faces Rising Cybersecurity Threats
Reveals Seqrite in ‘India Cyber Threat Report 2025’ Indis healthysoch Pune/New Delhi, December 20, 2024: The healthcare sector in India…
Suggestions
Dr. Agarwals Eye Hospital opens it’s first Eye Clinic in Bengaluru at Kengeri
Announces Free Eye Check-ups for the Public Until 31st October 2024 India healthysoch Bengaluru, September 18, 2024: Dr. Agarwal’s Group…
QCI NABH Mark World Patient Safety Day 2024 with Major Healthcare Reforms
India healthysoch New Delhi, September 18, 2024: The National Accreditation Board for Hospitals and Healthcare Providers (NABH), a constituent Board…
Predisease State of COPD: Early Indicator of COPD Risk and Progression
Author: Dr Surya Kant, Professor and Head, Dept. of Respiratory Medicine, KGMU, Lucknow, UP. National Vice Chairman IMA-AMS India healthysoch…
Indian Immunologicals Limited (IIL) launches multiple Indigenous In-vitro Fertilization Media for Embryo Transfer
IIL in collaboration with National Dairy Development Board (NDDB), launches a series of indigenous In-vitro Fertilization to the domestic market with Brand Name…
Nonagenarian Achieves Smooth Recovery Following Laparoscopic Sigmoidectomy
India healthysoch Bengaluru, September 13, 2024: Mrs. Gayatri (Name changed), a nonagenarian 94-year-old, has been dealing with bleeding in her…
Dr. Agarwal’s Eye Hospital, Whitefield Hosts Walkathon to increase Eye Donation Awareness
India healthysoch Bangalore, September 13, 2024: In a remarkable demonstration of resilience and hope, Mrs. Sunita (name changed), a corneal…
Mpox can spread in large gatherings ?
Author: Dr. Swati Rajagopal, Consultant – Infectious Disease & Travel Medicine, Aster CMI Hospital, Bangalore India healthysoch New Delhi, September…
Life-Saving Collaboration: Aster CMI Hospital and Coal India Provide Bone Marrow Transplants
India healthysoch Bengaluru, September 10, 2024: Aster CMI Hospital and Coal India Ltd have partnered to provide life-saving bone marrow…
Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
A novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS) Usnoflast, is a “First-in-class” NLRP3 inhibitor to…
Healthcare Summit 2024:Revolutionizing Indian Healthcare
Embracing Innovation India healtysoch New Delhi, September 10, 204: As India’s healthcare sector is poised for significant growth, projected to…
HealthySoch